As cannabis use continues to increase in the U.S., researchers from The University of Oklahoma are investigating whether it ...

This guide for newly diagnosed patients provides key information to help you understand your options and have informed ...

A new analysis finds that nearly half of head and neck cancer trials go unpublished, particularly those that lack ...

Cancer patients tend to use cannabis to manage side effects of their treatment and ease symptoms such as nausea, pain, insomnia and anxiety. “Research has shown that there is a high rate of cannabis ...

This is where Robot assisted surgery has transformed the landscape of head and neck cancer treatment. Unlike conventional ...

Cancer cells can break down the protective covers around nerves, causing nerve injury that triggers chronic inflammation, leading to immune exhaustion and eventual resistance to immunotherapy, ...

Researchers at MUSC Hollings Cancer Center have discovered a potentially powerful weapon in the fight against head and neck cancers. The new drug, still in preclinical studies, attacks cancer cells ...

PDS0101 and pembrolizumab combination achieved a median overall survival of 39.3 months in HPV16-positive head and neck cancer patients with a CPS of at least 1. The VERSATILE-002 trial showed ...

Human papilloma virus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus, with rates increasing each year.

PDS Biotech has reported final phase 2 data on PDS0101 in the tough-to-treat head and neck cancer setting, linking a combination of the immunotherapy and Keytruda to median overall survival (OS) of 39 ...